Introduction
============

Despite improvement in early detection and advances in treatments, leukemia continues to be a major cause of morbidity and mortality worldwide ([@b6]). Treatment options remain limited and are fraught with adverse side effects ([@b14]; [@b39]; [@b44]; [@b45]). Thus, studies into the use of nontoxic dietary agents are rapidly gaining ground and many natural agents are currently under investigation as potential chemo-preventive as well as chemotherapeutic agents including investigations in a number of clinical trials ([@b25]; [@b46]; [@b37]).

The fruit of the pomegranate tree (*Punica granatum*) has shown great promise as an anti-cancer agent in lung ([@b24]), prostate ([@b37]), skin ([@b3]), colon ([@b1]), and breast cancer ([@b27]), which has been taken into phase II clinical trials in prostate cancer ([@b2]; [@b37]). We have previously shown that crude extracts of pomegranate juice (PGJ) induce apoptosis and inhibit cell cycle in a number of leukemia cell lines, which demonstrated greater sensitivity than nontumor control cells ([@b8]).

However, to date, the compounds responsible for the anti-leukemic properties of pomegranate remain unknown. PGJ contains a number of potential active compounds including organic acids, vitamins, sugars, and phenolic components. The phenolic components include phenolic acids: principally, hydroxybenzoic acids (such as gallic acid and ellagic acid) ([@b4]); hydroxycinnamic acids (such as caffeic acid and chlorogenic acid) ([@b10]); anthocyanins, including glycosylated forms of cyanidin, delphinidin, and pelargonidin ([@b12]; [@b29]); and gallotannins and ellagitannins ([@b4]). In addition, PGJ contains glucose, fructose, water, and organic acids (including ascorbic and citric acid) ([@b29]). However, the concentration and the contents of these compounds vary due to growing region, climate, cultivation practice, and storage conditions ([@b38]; [@b10]; [@b31]).

Here, we used solid phase extraction (SPE) to fractionate PGJ and determine which fractions induced apoptosis and cell cycle arrest using two lymphoid and two myeloid cell lines, which we previously demonstrated were sensitive to crude pomegranate extracts ([@b8]). We assessed the polyphenol composition of the fractions by liquid chromatography mass spectrometry (LC--MS) to identify active compounds within fractions of PGJ, and treated cells individually with pure compounds identified to investigate potential agents.

Materials and Methods
=====================

Sample preparation and fraction separation from PGJE
----------------------------------------------------

SPE using Strata C18E GIGA tubes (Phenomenex, Hartsfield, U.K.) was used to separate fractions from pomegranate juice extract (PGJE). First, tubes were pre-equilibrated by washing with 50 mL of acetonitrile then 50 mL of 0.1% formic acid/ultra pure water (v/v) (Sigma, Poole, U.K.). PGJE derived from fresh pomegranates (Sainsbury\'s U.K.) prepared as previous ([@b8]) were sterile filtered through 0.22 μm syringe filter (Invitrogen, Paisley, U.K.) and diluted 1:1 with sterile distilled water, then 50 mL of this diluted juice was added to the SPE unit. The unbound compounds which passed directly through the column were collected (fraction A: unbound fraction). Then, 50 mL each of ultra pure water, acetonitrile, acetone, and ethyl acetate were added to the tube to collect water (fraction B), acetonitrile (fraction C), acetone (fraction D), and ethyl acetate (fraction E) fractions, respectively, as described previously ([@b48]). Each fraction was dried using freeze drying (MODULYOD-230 freeze dryer, Thermo, U.K.) at −30 to −80°C for fractions A and B or dried under a nitrogen stream at room temperature for fractions C, D, and E. The water, unbound, and acetonitrile fractions were dissolved in distilled water; the acetone fraction in methanol; and ethyl acetate fraction in DMSO to the required dilution (Sigma, Poole, U.K.).

Treatments
----------

The dried weight (DW) of each SPE fraction was recorded and added to give the total weight of all dried fractions. Dried fractions were then resuspended in appropriate solvents to give a concentration (mg DW/mL) equal to that of the 6.25% dilution of whole PGJE used previously ([@b8]). Cells (0.5 × 10^6^ per well) were then treated with 1, 2, and 4 μL of each fraction solution, which was equivalent to the concentration in 6.25%, 12.5%, and 25% PGJE (as studied previously ([@b8])) for 48 and 72 h.

Cell lines and culture
----------------------

Four leukemia cell lines were obtained from the American Type Culture Collection (ATCC; Middlesex, U.K.), which our previous study demonstrated differing sensitivity to PGJE ([@b8]). Two lymphoid cell lines: CCRF-CEM (acute lymphoblastic leukemia) (ATCC: CCL-119), and MOLT-3 (acute lymphoblastic leukemia patient released following chemotherapy) (ATCC: CRL-1552), and two myeloid cell lines: HL-60 (Human promyelocytic leukemia) (ATCC: CCL-240) and THP-1 (acute monocytic leukemia) (ATCC: TIB-202). Cell lines were maintained and cultured in RPMI 1640 medium (Invitrogen, Paisley, U.K.) supplemented with 10% (v/v) fetal bovine serum, 1.5 mmol/L [l]{.smallcaps}-glutamine, and 100 μg/mL penicillin/streptomycin (complete media) in a humidified atmosphere of 5% CO~2~ at 37°C.

Cells were seeded in 12-well plates (Fisher Scientific, Loughborough, U.K.) at a cell density of 0.5 × 10^6^ cells per well and treated individually with the five fractions (unbound \[i.e., compounds which passed directly through the column\] and fractions eluted with water, acetonitrile, acetone, and ethyl acetate fractions) at equivalent compound weights seen in 0%, 6.25%, 12.5%, and 25% whole PGJE, all treatments were performed in triplicate. Following treatment, cells were investigated for induction of apoptosis and inhibition of cell proliferation following 24, 48, and 72 h.

Cell viability
--------------

The effect of SPE fractions (unbound, water, acetonitrile, acetone, and ethyl acetate) on the viability of cells was determined by the Cell Titer-Glo® Luminescent Cell Viability Assay (Promega, Southampton, U.K.) which measures total adenosine triphosphate (ATP) present, indicating the number of metabolically active cells. Cells were seeded at 25 × 10^4^ cells in 100 μL of complete media and treated with each fraction at a concentration equivalent to that seen in 0%, 6.25%, 12.5%, and 25% whole PGJE in white 96-well plate (Fisher Scientific) for 72 h. Control wells were prepared which contained only medium or treatments without cells to determine background luminescence. Following 48 h incubation, the plate and its contents was equilibrated at room temperature for 30 min. Then, 100 μL of Cell Titer-Glo® Reagent was added to each well, mixed well for 2 min on an orbital shaker at 400 rpm, and then incubated at room temperature for 10 min prior to luminescence detection using Wallac 1420 luminescence detector (PerkinElmer, Cambridge, U.K.).

Caspase-3 activity
------------------

NucView™ 488 Caspase-3 substrate (Cambridge Bioscience, Cambridge, U.K.) was used for detection of apoptosis. Cells were plated in 12-well plates (Fisher Scientific) and then treated with PGJE fractions (unbound, water, acetonitrile (ACN), acetone, and ethyl acetate) at concentrations equivalent to their component concentrations seen in 0--25% whole PGJE for 48 h. Following incubation, 200 μL of cell suspension was added to flow cytometry tubes and 5 μL of NucView™ 488 Caspase-3 substrate was added directly into the cell suspension and mixed well. Cells were incubated for 20 min at room temperature protected from light. Following incubation, 300 μL of Dulbecco\'s phosphate-buffered saline (DPBS) (Invitrogen, Paisley, U.K.) was added and samples were analyzed directly on a FACS Calibur Cytometer (Becton- Dickinson, U.K.). Data were recorded from 10,000 cells per sample and analyzed using FlowJo software (Tree Star, Ashland, OR).

Annexin V/PI FITC flow cytometry assay
--------------------------------------

Annexin V/PI fluorescein isothiocyanate (FITC) stains were used to detect apoptosis based on flow cytometry as described previously ([@b8]). Data were recorded from 10,000 cells per sample and analyzed using FlowJo software (Tree Star).

Hoechst 33258 and propidium iodide staining
-------------------------------------------

Hoechst 33258 and propidium iodide (PI) staining was used to observe the apoptotic/necrotic morphology of CCRF-CEM, MOLT-3, HL-60, and THP-1 cells. In brief, 0.25 × 10^5^ cells/mL were seeded into 12-well plates and incubated for 24 h following treatment with acetonitrile fractions at concentrations equivalent to component concentrations seen in 0--25% whole PGJE. Then, 1 μL of PI (50 μg/mL) and 5 μL of Hoechst 33258 (10 mg/mL) stains were added to each well and incubated at 37°C for 15 min. Cells were investigated using Olympus inverted fluorescence microscope at excitation wavelength 350 nm and 488 nm dual wavelength filter and images were captured using Q Capture-Pro 8.0 (UVP BioImaging Systems, Loughborough, U.K.).

Cell cycle
----------

The cell cycle distribution of leukemia cell lines was measured by the DNA contents in each cell based on flow cytometry using PI stain as described previously ([@b8]). Data from 10,000 cells per sample were recorded and percentages of cells within G~0~/G~1~, S, and G~2~/M cell cycle phase were determined with FlowJo software and Waston (pragmatic) analysis of cell cycle (Tree Star).

Liquid chromatography mass spectrometry
---------------------------------------

Samples (containing 20 μg gallic acid equivalents \[GAE\]s by Folin assay) were analyzed on a LCQ-DECA system, comprising Surveyor autosampler, pump and photo diode array detector (PDAD), and a Thermo-Finnegan mass spectrometer iontrap (Stoke on Trent, U.K.). The PDAD scanned three discrete channels at 280, 365, and 520 nm. Samples were eluted with a linear gradient of 5% acetonitrile (0.1% formic acid) to 30% acetonitrile (0.1% formic acid) on C18 column (Synergi Hydro C18 with polar end capping 2.0 mm × 150 mm) (Phenomenex, Hartsfield, U.K.) over 60 min at a rate of 200 μL/min. For the pellet samples, the gradient was altered (*t* = 0, 5% acetonitrile; *t* = 10 min, 12.5% acetonitrile; and *t* = 60 min, 30% acetonitrile) to try to separate the later eluting ellagitannins. The LCQ-DECA LC--MS was fitted with an electrospray ionization interface and the samples were analyzed in positive and negative ion mode. There were two scan events: full scan analysis followed by data-dependent MS/MS of the most intense ions. The data-dependant MS/MS used collision energies (source voltage) of 45% in wideband activation mode. The MS detector was tuned against cyanidin-3-*O*-glucoside (positive mode) and against ellagic acid (negative mode).

Determination of total phenolics
--------------------------------

The content of the total phenolics was evaluated by using the Half Strength Folin--Ciocalteu method adapted from ([@b9]). First, 250 μL Folin--Ciocalteu reagent (Sigma Gillingham, U.K.) was added to 250 μL of each fraction (unbound, water, acetonitrile, acetone, and ethyl acetate) (1% diluted with water) and mixed gently prior to 3 min at room temperature. Then, 250 μL of sodium carbonate solution was added to each sample, mixed well, and incubated for 1 h prior to recording at 750 nm using Ultrospec™ 2100 *pro* UV/Visible Spectrophotometer (GE Healthcare Life Sciences, Buckinghamshire, U.K.). Gallic acid was used as a standard and total phenolic was expressed as GAEs.

Pure compound treatments
------------------------

Punicalagin and ellagic acid were purchased from Sigma (Pool, U.K.), and delphinidin-3-glucoside and cyanidin-3-glucoside were purchased from Extrasynthese (Geny, France). All four cell lines were treated with pure compounds at concentrations (0, 5, 10, 25, 50, and 100 μmol/L) for 24 h to test their effects on cell viability using the Cell Titer-Glo® Luminescent cell viability assay as described above.

Statistical analysis
--------------------

Means and standard error of the mean (SEM) were calculated and a Shapiro--Wilk test (Stats Direct, Cheshire, U.K.) was used to test whether data followed a normal distribution. Data were nonparametric and thus a Kruskal--Wallis test and a Conover--Inman post hoc test were used to investigate significant differences. Results were considered statistically significant when *P* ≤ 0.05.

Results
=======

Differential effects of pomegranate fractions on ATP levels
-----------------------------------------------------------

Whole PGJE induced a dose-dependent inhibition of ATP levels within all four leukemia cell lines (*P* ≤ 0.05) ([Fig. 1](#fig01){ref-type="fig"}). The acetonitrile fraction obtained after SPE induced a significant decrease in ATP levels (*P* ≤ 0.05) which showed a nonsignificant increase in cytotoxicity compared to the whole juice extracts ([Fig. 1](#fig01){ref-type="fig"}). Low-dose treatments of leukemia cell lines with either whole PGJE or the acetonitrile fractions demonstrated dramatic reduction in ATP levels indicating decreased cell viability following 24 h treatment ([Fig. 1](#fig01){ref-type="fig"}). The unbound, water, acetone, and ethyl acetate SPE fractions had minimal effects on any cell line at the doses investigated (concentration equivalent to those present in 6.25%, 12.5%, and 25% whole PGJE treatments) ([Fig. 1](#fig01){ref-type="fig"}).

![Effect of water, unbound, acetonitrile, acetone, and ethyl acetate fractions generated by SPE of PGJE together with whole PGJE in four leukemia cell lines (CCRF-CEM, MOLT-3, HL-60, and THP-1). Cells were treated for 48 h with all fractions at concentrations equivalent to the concentration of compounds within 6.25%, 12.5%, and 25% whole PGJE. ATP levels were investigated using the Cell Titer-Glo® Luminescent Cell Viability Assay to provide indication of live cell numbers. ATP levels normalized to controls and presented as means ± standard error. \*Significant difference (*P* ≤ 0.05). SPE, solid phase extraction; PGJE, pomegranate juice extract; ATP, adenosine triphosphate.](fsn30001-0196-f1){#fig01}

Effect of acetonitrile fraction from pomegranate juice on cell cycle arrest within leukemia cell lines
------------------------------------------------------------------------------------------------------

Treatment of leukemia cells lines with the acetonitrile fraction for 48 h demonstrated significant S phase arrest within all four cell lines (*P* \< 0.05) with a corresponding significant decrease in cells within G~0~/G~1~ phase at all concentrations (*P* \< 0.05) ([Fig. 2](#fig02){ref-type="fig"}).

![Effect of acetonitrile fraction generated by SPE of PGJE on cell cycle phase distribution in four leukemia cell lines (CCRF-CEM, MOLT-3, HL-60, and THP-1). Cells treated for 48 h with acetonitrile fraction at concentrations equivalent to those found in 6.25%, 12.5%, and 25% whole PGJEs. Means ± standard error shown. \*Significant difference (*P* ≤ 0.05). SPE, solid phase extraction; PGJE, pomegranate juice extract.](fsn30001-0196-f2){#fig02}

Induction of apoptosis by acetonitrile SPE fraction from pomegranate extracts within leukemia cell lines
--------------------------------------------------------------------------------------------------------

The acetonitrile fraction induced apoptosis in a dose-dependent manner in all four leukemia cell lines following 24, 48, and 72 h incubation. CCRF-CEM was the most sensitive cell line and THP-1 cells were the least affected ([Fig. 3](#fig03){ref-type="fig"}). Induction of apoptosis by treatment with the acetonitrile fraction was confirmed with the induction of caspase-3 activity in a time- and dose-responsive manner in all cell lines (*P* \< 0.05) ([Fig. 4](#fig04){ref-type="fig"}). Microscopic examination also demonstrated a marked increase in the number of cells displaying apoptotic morphology (such as chromatin condensation and fragmentation), in addition to a decrease in the number of live cells displaying normal nuclear morphology in all cell lines ([Fig. 5](#fig05){ref-type="fig"}).

![Effect of acetonitrile fraction generated by SPE of PGJE on induction of apoptosis in four leukemia cell lines (CCRF-CEM, MOLT-3, HL-60, and THP-1). Cells treated for 24, 48, and 72 h with acetonitrile fraction at concentration equivalent to the concentrations of compounds found in 6.25%, 12.5%, and 25% whole PGJE. Induction of apoptosis was determined by Annexin V-FITC/PI based on flow cytometry analysis. Means ± standard error. \*Significant difference (*P* ≤ 0.05). SPE, solid phase extraction; PGJE, pomegranate juice extract; PI, propidium iodide.](fsn30001-0196-f3){#fig03}

![Effect of acetonitrile fraction generated by SPE of PGJE on caspase-3 activation in four leukemia cell lines (CCRF-CEM, MOLT-3, HL-60, and THP-1). Cells treated for 24, 48, and 72 h with acetonitrile fraction equivalent to the concentrations of compounds found in 6.25%, 12.5%, and 25% whole PGJE. Caspase-3 activation was determined by NucView™ 488 Caspase-3 substrate based on flow cytometry analysis. Means ± standard error of the mean. \*Significant difference (*P* ≤ 0.05). SPE, solid phase extraction; PGJE, pomegranate juice extract.](fsn30001-0196-f4){#fig04}

![Effect of acetonitrile fraction generated by SPE of PGJE on morphology of apoptotic cells in HL-60. Cells treated for 48 h at concentration 6.25%, 12.5%, and 25%. Apoptotic morphology was determined by Hoechst 33258 and PI staining. SPE, solid phase extraction; PGJE, pomegranate juice extract; PI, propidium iodide.](fsn30001-0196-f5){#fig05}

Phenolic content of SPE fractions
---------------------------------

The acetonitrile fraction generated by SPE had the highest phenol content of 2696.7 μg GAE/mL, which was more than double than that seen within whole juice extracts (1236.9 μg GAE/mL), whereas the phenol content of other extracts was minor in comparison with 53.5 μg GAE/mL in the unbound fraction, 148.2 μg GAE/mL in the water fraction, 46.0 μg GAE/mL in the acetone fraction, and 5.7 μg GAE/mL in the ethyl acetate fraction. This translated to concentrations of phenol content of 6.25% equivalent treatments containing 5.2 μg/mL GAE within acetonitrile treatments and 2.4 μg/mL GAE within 6.25% treatments with whole PJE. Other fractions contained negligible levels of phenols which correlated with no observable biological activity ([Fig. 1](#fig01){ref-type="fig"}).

LC--MS of whole PGJE and SPE Fractions
--------------------------------------

LC--MS was carried out on the whole PGJE and each fraction generated from the SPE procedure on samples containing 20 μg GAE. Virtually all the material from the unbound fraction and the water fraction was not retained and eluted in the column wash (data not shown). Previous work has shown that these fractions contain organic acids, vitamin C, and sugars. The juice contained peaks characteristic of phenolic components previously found in pomegranate ([@b17]) and included gallotannins, ellagitannins, anthocyanins, and hydroxycinnamic acid derivatives ([Figs. 6](#fig06){ref-type="fig"} and [7](#fig07){ref-type="fig"}; [Table 1](#tbl1){ref-type="table"}). The acetonitrile fraction had the highest intensity of peaks but had a similar composition to the whole PGJE. The acetone and ethyl acetate fractions contained lower amounts of phenolic materials but certain components were enhanced in these fractions ([Fig. 6](#fig06){ref-type="fig"}). Comparison of whole PGJE and the acetonitrile fraction ([Fig. 7](#fig07){ref-type="fig"}A) demonstrated that the acetonitrile fraction was enriched in a number of ellagitannins, ellagic acid, and hydroxycinnamic acid derivatives over the juice ([Fig. 7](#fig07){ref-type="fig"}A and [Table 1](#tbl1){ref-type="table"}). However, it was clear that the acetonitrile fraction was depleted in anthocyanins compared to whole juice extract ([Fig. 7](#fig07){ref-type="fig"}A) but all the anthocyanins in the juice were also present in the acetonitrile fraction but at around eightfold lower levels ([Fig. 7](#fig07){ref-type="fig"}B; [Table 1](#tbl1){ref-type="table"}). The anthocyanins identified within both the whole juice extracts and acetonitrile fraction included the characteristic glycosylated forms of delphinidin, cyanidin, and pelargonidin ([Fig. 7](#fig07){ref-type="fig"}B; [Table 1](#tbl1){ref-type="table"}) found in pomegranate.

###### 

Putative identification of phenolic components

  Peak   PDA *max*   *m/z* \[M-H\]   MS^2^           Putative identity
  ------ ----------- --------------- --------------- ---------------------------------
  1      275         783             481, 301        Punicalagin 1 (bis-HHDP-hexose)
  2      275         1569            935, 785, 765   Sanguiin H-10-like isomer
  3      275         1569            935, 785, 765   Sanguiin H-10-like isomer
  4      280         1569            935, 785, 765   Sanguiin H-10-like isomer
  5      275         581             301             EA derivative
  6      290         507             327, 315        Methyl EA derivative
  7      330         533             353             HCA derivative
  A1     520         627^+^          303             Del-3, 5-diglc
  A2     512         611^+^          287             Cy-3, 5-diglc
  A3     500         595^+^          271             Pg-3, 5-diglc
  A4     520         465^+^          303             Del-3-glc
  A5     515         449^+^          287             Cy-3-glc
  A6     500         433^+^          271             Pg-3-glc
  A7     505         419^+^          289             Cy-pentose

Putative identifications are taken from (Mullen et al. [@b36]; Fischer et al. [@b7]). The MS data for the anthocyanins (peaks A1--7) was obtained in positive mode.

![LC--MS chromatographs of whole PGJE (A) and acetonitrile (B), acetone (C) and ethyl acetate fractions (D) from solid phase extraction of PGJE LC--MS performed on samples containing 20 μg GAE/mL by follin assay. LC--MS, liquid chromatography mass spectrometry; PGJE, pomegranate juice extract; GAE, gallic acid equivalent.](fsn30001-0196-f6){#fig06}

![LC--MS chromatographs of whole PGJE (Black) and acetonitrile solid phase fraction from PGJE (Blue) demonstrating peak differences within negative ion mode (A) and positive ion mode (B). \*The main peaks in juice sample that differ from the ACN fraction. The identities of peaks labeled are discussed in [Table 1](#tbl1){ref-type="table"}. LC--MS, liquid chromatography mass spectrometry; PGJE, pomegranate juice extract.](fsn30001-0196-f7){#fig07}

Effect of pure compounds on ATP levels as an indicator of cell viability
------------------------------------------------------------------------

Pure compounds (punicalagin, ellagic acid, delphinidin-3-*O*-glucoside, and cyanidin-3-*O*-glucoside) significantly inhibited ATP levels in all four leukemia cell lines ([Fig. 8](#fig08){ref-type="fig"}). Punicalagin and delphinidin-3-*O*-glucoside were the most effective compounds although they displayed differential sensitivity toward the four cell lines investigated. Interestingly, the sensitivity of cell lines to punicalagin (IC~50~ CCRF \[5 μmol/L\] \>HL-60 \[17 μmol/L\] \>MOLT-3 \[18 μmol/L\] \>THP-1 \[69 μmol/L\]) ([Fig. 8](#fig08){ref-type="fig"}) was identical to the order of sensitivity seen following acetonitrile fraction treatments ([Fig. 1](#fig01){ref-type="fig"}). Whilst delphinidin-3-glucoside was most toxic to HL-60 cells with an IC~50~ of 19 μmol/L compared to 35 μmol/L for CCRF and MOLT-3 ([Fig. 8](#fig08){ref-type="fig"}). Cyanidin-3-glucoside required high concentrations to inhibit 50% of cells (IC~50~: 89--91 μmol/L), whilst ellagic acid failed to reach 50% inhibition in all but MOLT-3 cells where a high dose of 89 μmol/L was required. Interestingly, THP-1 was the least sensitive to any compound a pattern mirrored with whole PGJ and that of the acetonitrile fraction.

![Effect of punicalagin, ellagic acid, delphinidin-3-glucoside, and cyanidin-3-glucoside on four leukemia cell lines (CCRF-CEM, MOLT-3, HL-60, and THP-1). Cells treated for 24 h with pure compounds at concentrations 0, 5, 10, 25, 50, and 100 μmol/L. ATP levels investigated using Cell Titer-Glo® Luminescent Cell Viability Assay to provide indication of live cell numbers. ATP levels normalized to controls and presented as means ± standard error. \*Significant difference (*P* ≤ 0.05). ATP, adenosine triphosphate.](fsn30001-0196-f8){#fig08}

Discussion
==========

Pomegranates have been postulated by a number of groups worldwide to provide bioactive compounds with anti-cancer actions, and have been successfully used in a number of randomized clinical trials for prostate cancer ([@b37]). We previously demonstrated that crude PGJ extract induced apoptosis and inhibited cellular proliferation inducing S phase arrest in leukemia cell lines ([@b8]). Here, we used SPE to separate the PGJ into fractions and identified that the acetonitrile fraction contained the bioactive compounds responsible for induction of apoptosis, cell cycle arrest, and inhibition of proliferation within leukemia cell lines.

LC--MS analysis confirmed that the PGJE contained the mixture of gallotannins, ellagitannins, anthocyanins, and hydroxycinnamic acid derivatives characteristic of pomegranate ([@b17]). Importantly, most of these components were recovered in the acetonitrile fraction with only a small proportion of phenolic components being identified in other fractions. The phenolic-enriched acetonitrile fraction was the most effective, and this strongly suggests that ellagitannins and other phenolic agents were responsible for its bioactive actions. Interestingly, we identified that the active acetonitrile fraction to be enriched in ellagitannins, but comparably depleted in anthocyanins.

A number of ellagitannins were identified as well as ellagic acid and hydroxycinnamic acid derivatives. Ellagitannins extracted from pomegranate have been previously shown to induce apoptosis in HL-60 cell lines ([@b32]). We observed similar proapoptotic affects when we treated this cell line together with other leukemia cell lines with the ellagitannin-rich acetonitrile fraction from PGJ. Similarly, ellagic acid has been shown to induce apoptosis within HL-60 cell lines, together with S phase arrest ([@b18]). This S phase arrest mimics that seen in our current study following treatment with the acetonitrile fraction and that seen in our previous study on whole PGJ ([@b8]). In contrast, ellagic acid and caffeic acid treatment of normal human peripheral blood mononuclear cells inhibited apoptosis induced by hydrogen peroxide treatments, suggesting that these compounds have protective effects on these cells ([@b26]). This was confirmed in our previous study where PGJ extracts showed a greater toxicity toward leukemia cell lines than nontumor control cells ([@b8]). This suggests that the ellagitannins within PGJ display protection to apoptosis in nontumor cells, but induce apoptosis in tumor cells. Treatment of cells with individual compounds demonstrated that ellagitannin: punicalagin mimicked the effects of the acetonitrile fraction from pomegranate suggesting that this may be one of the major bioactive compounds within pomegranate. Interestingly, in contrast, ellagic acid induced limited effects and failed to inhibit 50% of cellular ATP levels in the majority of cell lines, which combined with the inhibition of apoptosis seen previously by ellagic acid ([@b26]) suggests that this would not be useful in leukemia therapies.

Induction of apoptosis by a number of hydroxycinnamic acids have also been seen within leukemia cell lines. Artepillin C, an extract from Brazilian propolis, has been shown to induce apoptosis and inhibit DNA synthesis resulting in S phase arrest ([@b28]).

Anthocyanins were also found in the acetonitrile fraction from PGJ although at lower levels than seen in whole PGJ. Anthocyanin treatment of leukemia cell lines have also demonstrated induction of apoptosis by a number of groups worldwide ([@b19], [@b20]; [@b23]; [@b15], [@b16]; [@b21]; [@b7]; [@b47]; [@b13]; [@b30]). We too demonstrated that anthocyanin inhibited ATP levels suggesting affects on apoptosis. This could account for some of the apoptosis induction within leukemia cells following treatment with the acetonitrile fraction from PGJ. However, although treatment of U937 cells (histocytic leukemia cell lines) with cyanidin and malvidin demonstrated G~2~/M phase arrest ([@b21]), 50% effectiveness was not reached until ∼50 μg/mL. The acetonitrile fraction was very effective at ∼50 μg GAE/mL and the anthocyanin content was less than ∼5% of the content. The eightfold depletion in anthocyanin content between PGJE and the acetonitrile fraction did not reduce effectiveness and this suggests that the actions within PGJ may not be due to the anthocyanin content. This is further supported by the finding that neither anthocyanin investigated was as effective as punicalagin in any cell line.

This study demonstrated that only the acetonitrile fraction demonstrated activity toward leukemia cell lines suggesting that the phenolic agents within pomegranate are responsible for induction of apoptosis and inhibition of cell proliferation. The relative enrichment of ellagitannins over anthocyanins and the closer agreement on affects of cell cycle seen with ellagitannins treatment of leukemia cell lines, together with the lower IC~50~ concentrations seen for punicalagin compared to the anthocyanins, suggest that ellagitannins may be the major players in the anti-cancer actions of pomegranate. However, it is highly probable that a number of compounds found within the acetonitrile fraction of PGJ interact with each other. Indeed, synergistic actions of ellagic acid with quercetin and resveratrol have been demonstrated previously in the leukemia cell line MOLT 4 cells ([@b34], [@b35]; [@b33]). [@b49]) found that individual treatment of human oral, colon, and prostate cancer cell lines with punicalagin, ellagic acid, and total pomegranate tannins failed to induce the same toxicity as whole pomegranate extracts suggesting that these agents either work synergistically or that other minor agents within PGJ are responsible for the actions of pomegranate ([@b40]). Conversely, our study demonstrated that treatment of leukemia cell lines with the acetonitrile fraction from pomegranate at concentrations determined to ensure equal concentrations of agents (not just phenolics) within the fractions to those in whole PGJ suggesting all the toxicity seen in PGJ was due to the agents seen within this acetonitrile fraction. SPE resulted in increased phenolic content of the acetonitrile fraction compared to the whole juice, which was not surprising as it is concentrated in phenolic compounds due to the loss of sugars and other compounds in the unbound and water fractions. Further studies will focus on combination of treatments of agents found within this study to identify potential synergistic actions between agents.

Of course, upon consumption of pomegranates, many of the compounds identified here do not enter the blood stream within this form. For example, the ellagitannins themselves do not enter the bloodstream ([@b40], [@b41], [@b43]; [@b11]). As such they cannot be effective directly against leukemic cells in vivo if delivered via oral consumption; however, these could be delivered via pharmacological means. However, oral delivery could still provide bioactivity from the ellagitannins as the colonic-derived metabolites, the urolithins, are known to circulate in the bloodstream ([@b40], [@b41], [@b43]; [@b11]), accumulate at certain sites ([@b42]), and are effective against cancer cell lines ([@b42]; [@b5]; [@b22]), and thus could provide the bioactive actions of consumed pomegranates.

The identification of the compounds responsible within pomegranate for the anti-cancer effects and interactions between other natural compounds and chemotherapy agents will be the next step toward understanding the role of pomegranates in cancer therapeutics.
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